Intraoperative seizure outcome of levetiracetam combined with perampanel therapy in patients with glioma undergoing awake brain surgery

View More View Less
  • 1 Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

OBJECTIVE

This study aimed to evaluate the efficacy of levetiracetam (LEV) combined with perampanel (PER) therapy for intraoperative seizure treatment to determine whether a combination of LEV and PER can aid in the prevention of intraoperative intractable seizures during awake surgery.

METHODS

The authors performed a retrospective cohort study in 78 consecutive patients with glioma who underwent awake surgery using intraoperative direct electrical stimulation mapping. To prevent intraoperative seizures, 50 patients were treated with the antiepileptic drug LEV only (LEV group) from January 2017 to January 2019, while the remaining 28 patients were treated with LEV plus PER (LEV + PER group) between March 2019 and January 2020. LEV (1000–3000 mg) and/or PER (2–4 mg) were administered before the surgery.

RESULTS

Preoperative seizures with International League Against Epilepsy (ILAE) class II–VI occurred in 44% of the patients in the LEV group and in 35.7% of patients in the LEV + PER group, with no significant difference between groups (p = 0.319). Total intraoperative seizures occurred in 18 patients (36.0%) in the LEV therapy group and in 2 patients (7.1%) in the LEV + PER group (p = 0.009). Of these, there were no patients (0%) with intractable seizures in the LEV + PER group. Regarding factors that influence intraoperative seizures in glioma patients during awake brain surgery, multivariate logistic regression models revealed that the occurrence of intraoperative seizures was significantly related to the involvement of motor-related regions (positive vs negative, HR 6.98, 95% CI 1.71–28.56, p = 0.007), preoperative seizure (ILAE class II–VI vs ILAE class I, HR 4.44, 95% CI 1.22–16.11, p = 0.024), and LEV + PER group (positive vs negative, HR 0.07, 95% CI 0.01–0.44, p = 0.005). Treatment-related adverse effects were rare and mild, including sleepiness, tiredness, and dizziness in both treatment groups.

CONCLUSIONS

This study demonstrates that LEV + PER therapy is significantly associated with a lower risk of intraoperative seizures compared with LEV therapy alone in patients with glioma during awake brain mapping. These findings will help neurosurgeons conduct safe and reliable awake surgeries and reduce the rate of intraoperative intractable seizures during such procedures.

ABBREVIATIONS

AMPA = α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ECoG = electrocorticogram; EOR = extent of resection; HR = hazard ratio; ILAE = International League Against Epilepsy; KPS = Karnofsky Performance Scale; LEV = levetiracetam; PER = perampanel; TIVA = total intravenous general anesthesia.

Illustration from Kim et al. (pp 1164–1172). Copyright Eui Hyun Kim. Published with permission.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42(5):10441056.

    • Search Google Scholar
    • Export Citation
  • 2

    Duffau H, Capelle L. Preferential brain locations of low-grade gliomas. Cancer. 2004;100(12):26222626.

  • 3

    Duffau H, Peggy Gatignol ST, Mandonnet E, et al. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with Grade II glioma in the left dominant hemisphere. J Neurosurg. 2008;109(3):461471.

    • Search Google Scholar
    • Export Citation
  • 4

    Aghi MK, Nahed BV, Sloan AE, et al. The role of surgery in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol. 2015;125(3):503530.

    • Search Google Scholar
    • Export Citation
  • 5

    Nossek E, Matot I, Shahar T, et al. Failed awake craniotomy: a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg. 2013;118(2):243249.

    • Search Google Scholar
    • Export Citation
  • 6

    Nossek E, Matot I, Shahar T, et al. Intraoperative seizures during awake craniotomy: incidence and consequences: analysis of 477 patients. Neurosurgery. 2013;73(1):135140.

    • Search Google Scholar
    • Export Citation
  • 7

    Eseonu CI, Eguia F, Garcia O, et al. Comparative analysis of monotherapy versus duotherapy antiseizure drug management for postoperative seizure control in patients undergoing an awake craniotomy. J Neurosurg. 2018;128(6):16611667.

    • Search Google Scholar
    • Export Citation
  • 8

    Moots PL, Maciunas RJ, Eisert DR, et al. The course of seizure disorders in patients with malignant gliomas. Arch Neurol. 1995;52(7):717724.

    • Search Google Scholar
    • Export Citation
  • 9

    Deutschman CS, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery. 1985;17(3):510517.

  • 10

    Gokhale S, Khan SA, Agrawal A, et al. Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures. Asian J Neurosurg. 2013;8(4):169173.

    • Search Google Scholar
    • Export Citation
  • 11

    Zachenhofer I, Donat M, Oberndorfer S, Roessler K. Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery. J Neurooncol. 2011;101(1):101106.

    • Search Google Scholar
    • Export Citation
  • 12

    Rossetti AO, Stupp R. Epilepsy in brain tumor patients. Curr Opin Neurol. 2010;23(6):603609.

  • 13

    Brodie MJ, Stephen LJ. Prospective audit with adjunctive perampanel: preliminary observations in focal epilepsy. Epilepsy Behav. 2016;54:100103.

    • Search Google Scholar
    • Export Citation
  • 14

    French JA, Krauss GL, Wechsler RT, et al. Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy: a randomized trial. Neurology. 2015;85(11):950957.

    • Search Google Scholar
    • Export Citation
  • 15

    Kwan P, Brodie MJ, Laurenza A, et al. Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: impact of mechanism of action and pharmacokinetics on clinical outcomes. Epilepsy Res. 2015;117:117124.

    • Search Google Scholar
    • Export Citation
  • 16

    Trinka E, Steinhoff BJ, Nikanorova M, Brodie MJ. Perampanel for focal epilepsy: insights from early clinical experience. Acta Neurol Scand. 2016;133(3):160172.

    • Search Google Scholar
    • Export Citation
  • 17

    Vecht C, Duran-Peña A, Houillier C, et al. Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations. J Neurooncol. 2017;133(3):603607.

    • Search Google Scholar
    • Export Citation
  • 18

    Yuen TI, Morokoff AP, Bjorksten A, et al. Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology. 2012;79(9):883889.

    • Search Google Scholar
    • Export Citation
  • 19

    Takano T, Lin JH, Arcuino G, et al. Glutamate release promotes growth of malignant gliomas. Nat Med. 2001;7(9):10101015.

  • 20

    Buckingham SC, Campbell SL, Haas BR, et al. Glutamate release by primary brain tumors induces epileptic activity. Nat Med. 2011;17(10):12691274.

    • Search Google Scholar
    • Export Citation
  • 21

    Wieser HG, Blume WT, Fish D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42(2):282286.

    • Search Google Scholar
    • Export Citation
  • 22

    Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522530.

    • Search Google Scholar
    • Export Citation
  • 23

    Iijima K, Motomura K, Chalise L, et al. Efficacy of the transtemporal approach with awake brain mapping to reach the dominant posteromedial temporal lesions. Acta Neurochir (Wien). 2017;159(1):177184.

    • Search Google Scholar
    • Export Citation
  • 24

    Motomura K, Natsume A, Iijima K, et al. Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas. J Neurosurg. 2017;127(4):790797.

    • Search Google Scholar
    • Export Citation
  • 25

    Motomura K, Chalise L, Ohka F, et al. Supratotal resection of diffuse frontal lower grade gliomas with awake brain mapping, preserving motor, language, and neurocognitive functions. World Neurosurg. 2018;119:3039.

    • Search Google Scholar
    • Export Citation
  • 26

    Motomura K, Chalise L, Ohka F, et al. Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping. J Neurosurg. 2020;132(6):16831691.

    • Search Google Scholar
    • Export Citation
  • 27

    Kim MH, Lee JH, Choi YS, et al. Comparison of the laryngeal mask airway supreme and the i-gel in paralysed elderly patients: a randomised controlled trial. Eur J Anaesthesiol. 2018;35(8):598604.

    • Search Google Scholar
    • Export Citation
  • 28

    Krauss P, Marahori NA, Oertel MF, et al. Better hemodynamics and less antihypertensive medication: comparison of scalp block and local infiltration anesthesia for skull-pin placement in awake deep brain stimulation surgery. World Neurosurg. 2018;120:e991e999.

    • Search Google Scholar
    • Export Citation
  • 29

    Nimsky C, Ganslandt O, Fahlbusch R. Implementation of fiber tract navigation. Neurosurgery. 2007;61(1)(suppl):306318.

  • 30

    Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):13381345.

    • Search Google Scholar
    • Export Citation
  • 31

    Motomura K, Natsume A, Kishida Y, et al. Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study. Cancer. 2011;117(8):17211730.

    • Search Google Scholar
    • Export Citation
  • 32

    Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009;15(19):60026007.

    • Search Google Scholar
    • Export Citation
  • 33

    Choi BD, Lee DK, Yang JC, et al. Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping. J Neurosurg. 2020;132(4):10171023.

    • Search Google Scholar
    • Export Citation
  • 34

    Serletis D, Bernstein M. Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg. 2007;107(1):16.

    • Search Google Scholar
    • Export Citation
  • 35

    Spena G, Roca E, Guerrini F, et al. Risk factors for intraoperative stimulation-related seizures during awake surgery: an analysis of 109 consecutive patients. J Neurooncol. 2019;145(2):295300.

    • Search Google Scholar
    • Export Citation
  • 36

    Sacko O, Lauwers-Cances V, Brauge D, et al. Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery. 2011;68(5):11921199.

    • Search Google Scholar
    • Export Citation
  • 37

    Boetto J, Bertram L, Moulinié G, et al. Low rate of intraoperative seizures during awake craniotomy in a prospective cohort with 374 supratentorial brain lesions: electrocorticography is not mandatory. World Neurosurg. 2015;84(6):18381844.

    • Search Google Scholar
    • Export Citation
  • 38

    Gonen T, Grossman R, Sitt R, et al. Tumor location and IDH1 mutation may predict intraoperative seizures during awake craniotomy. J Neurosurg. 2014;121(5):11331138.

    • Search Google Scholar
    • Export Citation
  • 39

    Spena G, Schucht P, Seidel K, et al. Brain tumors in eloquent areas: a European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis. Neurosurg Rev. 2017;40(2):287298.

    • Search Google Scholar
    • Export Citation
  • 40

    Hervey-Jumper SL, Li J, Lau D, et al. Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period. J Neurosurg. 2015;123(2):325339.

    • Search Google Scholar
    • Export Citation
  • 41

    Steinhoff BJ, Ben-Menachem E, Ryvlin P, et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia. 2013;54(8):14811489.

    • Search Google Scholar
    • Export Citation
  • 42

    Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011;11(2):5663.

  • 43

    French JA, Krauss GL, Biton V, et al. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology. 2012;79(6):589596.

    • Search Google Scholar
    • Export Citation
  • 44

    Kanemura H, Sano F, Aihara M. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy. Eur J Paediatr Neurol. 2019;23(1):197203.

    • Search Google Scholar
    • Export Citation
  • 45

    Liguori C, Izzi F, Manfredi N, et al. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: a retrospective single center study. Epilepsy Behav. 2018;80:173176.

    • Search Google Scholar
    • Export Citation
  • 46

    Chonan M, Saito R, Kanamori M, et al. Experience of low dose perampanel to add-on in glioma patients with levetiracetam-uncontrollable epilepsy. Neurol Med Chir (Tokyo). 2020;60(1):3744.

    • Search Google Scholar
    • Export Citation
  • 47

    Ettinger AB, LoPresti A, Yang H, et al. Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel. Epilepsia. 2015;56(8):12521263.

    • Search Google Scholar
    • Export Citation
  • 48

    Chung S, Williams B, Dobrinsky C, et al. Perampanel with concomitant levetiracetam and topiramate: post hoc analysis of adverse events related to hostility and aggression. Epilepsy Behav. 2017;75:7985.

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 153 153 153
Full Text Views 77 77 77
PDF Downloads 100 100 100
EPUB Downloads 0 0 0